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Summary
Background: Tuberculosis (TB) remains an important public health problem in Canadian Abori-
ginal (First Nations and Inuit) communities. The objectives of this study were to predict future
disease burden and set feasible targets for the elimination of TB in the First Nations population,
using retrospective data and an epidemic model.
Methods: Reported TB incidence data (1974—2002), previously published TB meningitis data
from the pre-chemotherapy era, and previous estimates of disease risk following infection were
used to estimate a trend in the annual risk of infection from 1929 to 2002, and the age-specific
prevalence of infection in 2002. A state-transfer, compartmental model was then developed to
predict future disease burden. Two scenarios were simulated, with different disease risk
parameters.
Results: The estimated prevalence of infection in 2002 was 20.9% in scenario 1 and 25.5% in
scenario 2. Predicted incidence rates in 2015 were 16.8 per 100 000 and 11.7 per 100 000 for the
two scenarios, respectively. The incidence of disease was not lower than 1 per 100 000 for either
scenario in 2034, the arbitrarily chosen last year of the model.
Conclusions: The goal of eliminating TB among Aboriginal peoples in Canada is a feasible one, but
will only be achieved with continued investment in programs designed to control and prevent
transmission. Reactivation disease cases may occur for a number of years to come, making rapid
elimination a difficult goal.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.* Corresponding author. Tel.: +1 613 884 6278.
E-mail address: mclar018@uottawa.ca (M. Clark).
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doi:10.1016/j.ijid.2008.06.021Introduction
Tuberculosis (TB) is an important public health problem in
Canadian Aboriginal (First Nations and Inuit) communities.
Rates of disease in the First Nations population remain 20—30Published by Elsevier Ltd. All rights reserved.
TB elimination in the Canadian First Nations population 221times higher than Canadian-born, non-Aboriginal rates.1—3 At
the global level, the Stop TB Partnership and the World
Health Organization have developed a plan for TB elimination
in the long term, with a focus on intensified measures in high-
burden populations.4 In Canada, a federal government strat-
egy to eliminate TB among First Nations people was imple-
mented in 1992. The original goal of this strategy was to
reduce TB incidence to less than one per 1 000 000 by 2010.5
Many experts considered this target to be unattainable,
leading to a review of program goals in 2005. The objective
remains TB elimination, although newer more long-term
targets for incidence reduction have been endorsed.6
Modeling techniques have been used to assess trends in
the annual risk of tuberculous infection (ARI) in popula-
tions,7—10 to assess the risk of disease following infec-
tion,11—13 and to estimate the impact of medical and
public health interventions on the overall epidemic.14—17
Using previously published estimates of disease risk13 and
TB case notification data for the period 1974—2002, we
estimated two possible ARI trends in the First Nations popu-
lation between 1929 and 2002. These trends produced two
potential scenarios for the age-specific prevalence of infec-
tion in 2002, and the risk of disease following tuberculous
infection. These data were then applied to a state-transfer,
compartmental model to predict future disease burden. The
objectives of the study were to predict future disease burden
and set feasible targets for TB elimination in the First Nations
population. The epidemiology and control of TB in this
population is then discussed in the context of our findings.
Methods
Estimation of the age-specific prevalence of
infection in 2002
Accurate estimates of the age-specific prevalence of tubercu-
lous infection in the overall First Nations population are lack-
ing. In order to estimate the prevalence of infection by one-
year age group in 2002, we used TB case notification data and
previously publisheddata onTBdisease risks.13 Age-specificTB
case notification data for the First Nations population in
Canada (‘Status Indians’ living on and off reserve) were sup-
plied by Health Canada, for the period 1974—2002. These data
(Status Indian TB cases by age group nationally) are available
to the public through annual Health Canada reports.1 Demo-
graphic data for the First Nations population living on and off
reserve (the ‘IndianRegistered Population’) between1974and
2002 were available by one-year age group from the Depart-
ment of Indian and Northern Affairs Canada. Trends in disease
incidence estimated in this studywere compared to previously
presented data,2 to assess their accuracy.
Using the 1974—2002 data set, we developed a maximum
likelihood model with the following assumptions. First, tal-
lies of disease cases in each age group a and each year t,
D(a,t), represent the sum of individuals experiencing disease
soon after primary infection P(a,t), endogenous reactivation
of latent infection years later En(a,t), and disease following
exogenous reinfection Ex(a,t), as shown in the following
expression:
Dða; tÞ ¼ Pða; tÞ þ Enða; tÞ þ Exða; tÞ (1)Age groups in these analyses included ten-year ranges from
15 to 64 years, similar to Sutherland et al.11 The states
P(a,t) and Ex(a,t) occur within one year of a new infection
with Mycobacterium tuberculosis. The first occurs among
persons previously unexposed to infection, while the latter
occurs among persons with a longstanding latent tubercu-
lous infection. This approach is similar to that of Dye and
colleagues.17 Assuming that individuals experience risks dp,
dn, and dx of developing disease following initial infection,
longstanding latent infection, and exogenous reinfection,
respectively, the above expression can be rearranged as
follows:
Dða; tÞ ¼ Iða; tÞd p þ Lða; tÞdn þ Rða; tÞdx (2)
where I(a,t) is the number of previously uninfected indivi-
duals acquiring a new infection within the last year, L(a,t) is
the number of people with longstanding latent infection, and
R(a,t) is the number of previously infected individuals experi-
encing re-infection with a new strain of M. tuberculosis.
Numbers of people in age group A at time t (where A spans
the ages aj, aj+1) in each of the three groups were calculated
using estimates of the ARI at different times t (ARI(t)) and
estimates of the prevalence of infection p among individuals
of age a at time t:
IðA; tÞ ¼
Xa jþ1
a¼a j
ARIðtÞ 1 pa1;t1
 
nða; tÞ (3)
RðA; tÞ ¼
Xa jþ1
a¼a j
ARIðtÞ pa1;t1nða; tÞ (4)
LðA; tÞ ¼
Xa jþ1
a¼a j
nða; tÞ pa;t  Rða; tÞ  Iða; tÞ (5)
where n(a,t) is the number of First Nations people of age a at
time t.
The prevalence of infection among individuals of age a at
time t was estimated as follows:
pa;t ¼ 1 exp 
Zt
ta
lðuÞdu
8<
:
9=
; (6)
where l(u) is the annual rate of tuberculous infection at time
u. This rate is related to the risk of infection at time u by:
ARI = 1  exp((u)). The risk of tuberculous infection may be
age-dependent,18 although this relationship remains unclear.
We assume no age-dependence, similar to the approach of
Vynnycky and Fine.10 Assuming that the infection rate
declines at a constant rate r over time, the above expression
simplifies to:
pa;t ¼ 1 exp
lðtÞ  lðt aÞ
r
 
(7)
Using the above data and mathematical equations, two
maximum likelihood models (referred to hereafter as ‘sce-
nario 1’ and ‘scenario 2’) were developed to estimate the ARI
between 1929 and 2002. In scenario 1, risks of disease
following infection were allowed to vary within confidence
222limits of previously published ranges:13 14—29% for dp, 2.8—
9.2% for dx, and 0.08—0.1% for dn. In scenario 2, risks of
disease were allowed to assume any value between 0 and 1.
The ARI trend and values for disease risk were thus estimated
by minimizing the following Poisson log-likelihood Chi-square
deviance function:
D ¼ 2
X
t
X
A
OA;tlnðDðA; tÞÞ  OA;tlnðOA;tÞ þ OA;t
 DðA; tÞ (8)
where OA,t is the number of observed (reported) TB disease
cases in age group A at time t.
In these analyses, ARI values between 1929 and 1947 were
fixed values, based on estimates from previously published
tuberculous meningitis data.13 The ARI then declines at
constant rate r after 1947, the year in which streptomycin
therapy began in Canada (isoniazid appearing shortly after-
wards in the early 1950s),19 andwhen TBmortality in the First
Nations population began a sharp decline.20 These methods
generate the most likely ARI trend — between 1948 and 2002
— to explain disease incidence between 1974 and 2002, and
to give estimates of the prevalence of infection by one-year
age category in 2002 through expression 6.
Rates of infectious TB were calculated for the period
1974—2002. TB cases were considered infectious if they were
sputum smear and/or sputum culture positive. Infectious TB
rates were then matched to ARI estimates for each year from
1974 to 2002, to estimate the number of transmissions per
case.
State-transfer compartmental model
Health states and possible transitions in the state-transfer,
compartmental model are depicted in Figure 1.
Difference equations for movement between states in the
compartmental model are provided below. In the following
equations, U(t,a) is written U, while U(t+1,a+1)  U(t,a) is
written U0.17 This applies to the uninfected state, as well as
the other states.
U0 ¼ lðtÞU (9)
M0 ¼ ðlðtÞð1 ðd pðaÞÞÞU  ðdnðaÞ þ lðtÞdxðaÞÞM
þ ðTi þ TnÞ (10)Figure 1 Health states and possible transitions in the state-
transfer, compartmental model.Ti
0 ¼ ðlðtÞd pðaÞÞ fðaÞU þ ðdnðaÞ
þ lðtÞdxðaÞÞ fðaÞM (11)
Tn
0 ¼ ðlðtÞd pðaÞÞð1 fðaÞÞU þ ðdnðaÞ
þ lðtÞdxðaÞÞð1 fðaÞÞM (12)
The M state includes all those infected with M. tuberculosis,
similar to the sum of I(a,t), R(a,t), and L(a,t) as described
above. In the above expressions, f (a) is the age-specific
probability that a TB disease case is infectious to others.
We assume that this value is 0 in children aged 0—14 years,
while 73% of those aged 15 or more years are assumed to be
infectious. Children are generally unable to produce sputum
until early adolescence. Although cavitary disease can occur
under the age of 15 years, children in this age category are
not commonly infectious.21 The estimate for individuals aged
15 years or more was derived from the TB data set described
above. Another simplifying assumption we make is that TB
disease cases are all treated and return to the infection
state,M. Although case fatality rates in Canada are markedly
lower than areas of the developing world, we do recognize
that deaths continue to occur.
The number of susceptibles U was assumed to increase by
2% each year, similar to previous population projections.22
Risks of disease were obtained from the maximum likelihood
methods of this study, with two exceptions. We assumed the
risk of disease among children aged less than 15 years was
29%,23 and that the risk of disease in persons aged more than
65 years approximated the risk among 45—64 year-olds.
Outcomes from analyses of the compartmental model
included predicted TB disease rates (overall and infec-
tious) by year, for scenarios 1 and 2. Simulations are run
M. Clark, D.W. CameronFigure 2 Estimated annual risk of infection (ARI) from 1929 to
2002 using the maximum likelihood model: (a) scenario 1; (b)
scenario 2.
Figure 3 Observed and predicted age-specific TB incidence rates (1974—2002): (a) scenario 1; (b) scenario 2. Markers are observed
rates with 95% confidence limits; lines are rates predicted by maximum likelihood model. Age groups (in years) are shown to the right.
TB elimination in the Canadian First Nations population 223until 2034, a year chosen somewhat arbitrarily for graphing
purposes. All above analyses were carried out using Micro-
soft1 Excel 2002.
Results
The estimated trends in ARI for scenarios 1 and 2 are shown in
Figure 2. Annual rates of decline in the ARI between 1947 and
2002 were 10.5% and 8.6% for scenarios 1 and 2, respectively.
Corresponding estimates of the ARI in 2002 were 0.05% and
0.13%. Scenario 1 predicted an overall prevalence of infec-
tion of 20.9% in 2002, while scenario 2 resulted in a pre-
valence of 25.5%. Observed and predicted rates of TB disease
incidence by age group are provided in Figure 3. Model
predictions of disease incidence in scenario 1 are poor for
older age groups, particularly in the 1970s. Predicted age-
specific rates fall within 95% confidence limits of observedrates for most years in both scenarios, and the vast majority
of data points in scenario 2.
Table 1 contains estimates of disease risk generated from
maximum likelihood exercises.
The reported infectious TB rate declined from 100 per
100 000 in 1974 to 13 per 100 000 in 2002 (Figure 4). Esti-
mates of the number of transmissions per infectious case are
higher in scenario 2 than in scenario 1. In scenario 1, the
number declines from 8.2 per case in 1974 to 3.8 per case in
2002. The number drops from 12.9 to 9.6 over the same
period in scenario 2.
Future predictions of TB disease incidence are given in
Figure 5. The predicted overall disease rate in 2010 is 20.1
per 100 000 in scenario 1, and 16.2 per 100 000 in scenario 2.
In 2015, these rates fall to 16.8 and 11.7 per 100 000,
respectively. Rates do not fall below 1 per 1 000 000 — or
below 1 per 100 000 — by 2034.
Table 1 Estimated risks of TB disease in scenarios 1 and 2
Risk category Age Scenario 1 (%) Scenario 2 (%)
Disease following initial infection, dp 15—24 21.1 15.4
25—34 21.5 17.5
35—44 21.3 18.8
45—54 21.6 20.8
55—64 21.6 21.5
Endogenous reactivation of latent infection, dn 15—24 8.02  102 5.84  103
25—34 8.36  102 1.81  104
35—44 8.00  102 1.00  104
45—54 8.10  102 1.41  103
55—64 9.61  102 2.24  102
Disease following exogenous reinfection, dx 15—24 5.23 1.43
25—34 5.75 9.60
35—44 6.65 16.6
45—54 7.48 22.6
55—64 7.12 22.6
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To our knowledge, this is the first attempt to estimate future
TB disease burden in the Canadian First Nations population,
using an epidemic model. We believe this is an important
exercise, given that targets previously set for elimination in
this population were chosen somewhat arbitrarily. Although
we agree that elimination is an important and attainable
goal, we also believe it is prudent to set realistic targets for
elimination. As one may expect at the tail end of an epidemic
curve, the rate of decline in TB incidence has slowed in
comparison to earlier years when TB incidence overall was
much higher. A similar trend was observed in the overallFigure 4 Observed infectious (pulmonary, sputum smear and/
or culture positive) TB and estimated number of transmissions
per infectious TB case by year (1974—2002): (a) scenario 1; (b)
scenario 2. Number of transmissions was estimated by matching
risk of infectious TB in each year with annual risk of infection
values generated by maximum likelihood model.Canadian population during the second half of the twentieth
century.24 This phenomenon is partly related to the increas-
ing proportion of cases resulting from endogenous reactiva-
tion, which are less likely to be prevented through aggressive
public health interventions. Reactivation disease can be
expected to occur in the First Nations population for a
number of years to come.
Several outcomes of the model are reassuring in terms
of their plausibility. Similar to expert opinion,25 our model
estimates the prevalence of infection in the Canadian First
Nations population was between 20% and 30% in 2000.
Annual rates of decline in the ARI between 1947 and
2002 for scenarios 1 and 2 were 10.5% and 8.6%, respec-
tively. These values are similar to estimates from other
populations in different studies (Table 2).7—9,13,26—28 TwoFigure 5 Observed overall and infectious TB rates (1974—
2002) and future overall and infectious TB rates (2002—2034)
predicted by state-transfer, compartmental model: (a) scenario
1; (b) scenario 2.
Table 2 Estimated annual rates of decline in the annual risk of tuberculous infection in different populations
Population Time period Annual rate of decline Reference
Sweden 1925—1945 9% 9
Netherlands 1940—1966 13% 7
Beijing, China 1950—1995 8% 26
Saskatchewan 1954—1971 11.6% 8
France 1965—1980 10.8% 27
Barcelona, Spain 1975—1991 8% 28
British Columbia First Nations 1979—2000 13.8% 13
TB elimination in the Canadian First Nations population 225recent studies have estimated an ARI of 0.03% in regional
First Nations populations, one in 200013 and the other in a
1998—2004 birth cohort.29 In the latter study, a worst-case
estimate of 0.22% was also calculated.29 Our estimates of
the ARI in 2002 were 0.05% and 0.13% for scenarios 1 and 2,
respectively. These values fall within the above range of
estimates, which were calculated from tuberculin skin
testing data.
For several reasons, scenario 2 provides a more plausible
model to explain disease incidence. First, it predicts
observed disease rates during the 1974—2002 period with
much greater accuracy (Figure 3). Second, futures rates
predicted by this scenario fall almost perfectly onto an
exponential trend line fit to the observed rates between
1974 and 2002 (Figure 6). This is what may be expected at
the tail end of an epidemic curve,24 as described above. In
this scenario, the number of transmissions per infectious TB
case is higher over time (ranging from 12.9 to 9.6 from 1974
to 2002), which is very plausible given the frequency and
intensity of TB outbreaks in First Nations communities.30—32
Estimated risks of reactivation of latent infection in scenario
2 are lower than in scenario 1, although they are closer to
values in other studies.11,12
Interestingly, risks of disease following exogenous rein-
fection in scenario 2 are quite high in older age categories,
and even exceed risks following primary infection in some
cases (Table 1). Although the latter observation may seem
implausible, it should be noted that the values are very
similar; this may reflect the distant exposure of many
elders in these communities, and resultant waning of
immunity. In other words, a history of distant infection
during the height of the TB epidemic may not confer muchFigure 6 Observed overall and infectious TB rates (1974—
2002) and future overall and infectious TB rates (2002—2034)
in scenario 2, with exponential trend lines fitted to observed
rates.protection — if any — against a new infection, particularly
among aging people who may have other medical risk
factors. Conditions such as diabetes mellitus, renal dis-
ease, and malnutrition have been identified as possible
risk factors for TB in First Nations individuals,6 although
these relationships have not been explored in depth. There
may also be a component of genetic susceptibility in
this population, elevating the risk of progression to TB
disease.33
The main limitation of any modeling exercise is that study
findings must be interpreted in light of the model’s assump-
tions. We have based model parameters on observations from
the Canadian First Nations population, so that assumptions in
the model were at the very least relevant to the study
population. Another limitation of this particular model was
its simplicity. Other models have considered the impact of
vaccination and treatment, along with additional health
states such as treatment failure, natural cure, and death.
It was not the objective of this study to estimate the poten-
tial impact of specific medical or public health interventions,
but rather the feasibility of elimination within certain time
frames given what we know about the epidemiology of TB in
this population.
A reduction to 1 per 1 000 000 people (translating to less
than one case in this population of less than 800 000 people)
by 2010 is not likely to happen. The potential consequence of
an unattainable goal is that successful programs may be
improperly evaluated, as they fail to achieve the impossible.
Program goals have recently been reviewed and changed, and
more realistic long-term targets for incidence reduction and
elimination have been set.6
Although we did not simulate any specific interventions,
one of the key parameters in the model is transmission.
Naturally, the degree of transmission and risk of infection
in the population will depend upon medical and public health
interventions. Elimination will be achieved by continuing to
prevent transmission of TB to younger generations, who then
in turn carry the bacillus for decades and may one day
themselves become transmitters. TB elimination in the Cana-
dian First Nations population will require continued commit-
ment at high levels, throughout the lifetime of several
elected governments.
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